Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / CRNX - Crinetics doses first patients in phase 2 clinical trials of CRN00808

CRNX - Crinetics doses first patients in phase 2 clinical trials of CRN00808

Crinetics Pharmaceuticals Inc.
  • Crinetics Pharmaceuticals (NASDAQ:CRNX) begins patients dosing in the ACROBAT EVOLVE and EDGE trials for CRN00808 in patients with acromegaly.
  • More news on: Crinetics Pharmaceuticals, Inc., Healthcare stocks news,
    • Read more ...
Stock Information
Company Name: Crinetics Pharmaceuticals Inc.
Stock Symbol: CRNX
Market: NASDAQ
Website: crinetics.com
Menu
CRNX CRNX Quote CRNX Short CRNX News CRNX Articles CRNX Message Board
Get CRNX Alerts

News, Short Squeeze, Breakout and More Instantly...